CymitQuimica logo

CAS 111223-26-8

:

Ceronapril

Description:
Ceronapril is an angiotensin-converting enzyme (ACE) inhibitor that is primarily used in the treatment of hypertension and heart failure. As a pharmaceutical compound, it works by inhibiting the enzyme responsible for converting angiotensin I to angiotensin II, a potent vasoconstrictor. This action leads to vasodilation, reduced blood pressure, and decreased workload on the heart. Ceronapril is characterized by its ability to improve cardiovascular outcomes and is often prescribed in conjunction with other antihypertensive agents. The compound has a specific chemical structure that contributes to its pharmacological activity, and it is typically administered orally. Like other ACE inhibitors, Ceronapril may have side effects, including cough, elevated potassium levels, and potential renal impairment, necessitating monitoring during treatment. Its efficacy and safety profile make it a valuable option in managing cardiovascular diseases, although individual responses may vary. As with any medication, it is essential for patients to consult healthcare professionals for personalized advice and management.
Formula:C21H33N2O6P
InChI:InChI=1S/C21H33N2O6P/c22-14-6-4-13-19(20(24)23-15-8-12-18(23)21(25)26)29-30(27,28)16-7-5-11-17-9-2-1-3-10-17/h1-3,9-10,18-19H,4-8,11-16,22H2,(H,25,26)(H,27,28)/t18-,19-/m0/s1
InChI key:InChIKey=IFYLTXNCFVRALQ-OALUTQOASA-N
SMILES:C([C@@H](OP(CCCCC1=CC=CC=C1)(=O)O)CCCCN)(=O)N2[C@H](C(O)=O)CCC2
Synonyms:
  • L-Proline, 1-[(2S)-6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-
  • Ceranapril
  • SQ 29852
  • 1-[(2S)-6-Amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline
  • L-Proline, 1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-, (S)-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.